Literature DB >> 6277338

Receptor binding sites for beta-adrenergic ligands on human erythrocytes.

G Sager.   

Abstract

Affinity, specificity and kinetics for [3H]-DHA binding to human red cell ghost were determined by ultra-filtration. At 2 degree an apparent dissociation constant of 0.96 nM was found with maximum specific binding of 29 fmoles per mg protein. The low dissociation constant was confirmed by kinetic studies with a value of 0.86 nM. Propranolol and isoproterenol inhibited [3H]-DHA binding stereo specifically. Agonist potency (IPR greater than EPI greater than NE) indicated that human erythrocytes had an adrenergic receptor of beta-2 subtype. Isoproterenol in the presence of theophylline resulted in a concentration-dependent increase of intracellular cAMP levels in intact cells. Basal and maximal levels were 2.3 and 7.5 pmoles/108 cells respectively after 2.5 min stimulation. EC50 for isoproterenol was 0.27 microM. Propranolol shifted the isoproterenol concentration response curve to the right. The present results show that human erythrocytes possess recognition sites for beta-adrenergic ligands with binding characteristics similar to that of adrenergic receptors of beta-2 subtype. At least a small number of these binding sites are functionally coupled to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277338     DOI: 10.1016/0006-2952(82)90243-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Inhibition of erythrocyte "apoptosis" by catecholamines.

Authors:  Philipp A Lang; Daniela S Kempe; Ahmad Akel; Barbara A Klarl; Kerstin Eisele; Marlies Podolski; Tobias Hermle; Olivier M Niemoeller; Philipp Attanasio; Stephan M Huber; Thomas Wieder; Florian Lang; Christophe Duranton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-25       Impact factor: 3.000

2.  Beta-adrenergic agonists regulate cell membrane fluctuations of human erythrocytes.

Authors:  S Tuvia; A Moses; N Gulayev; S Levin; R Korenstein
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

3.  Effect of propranolol as antiadhesive therapy in sickle cell disease.

Authors:  Laura M De Castro; Rahima Zennadi; Jude C Jonassaint; Milena Batchvarova; Marilyn J Telen
Journal:  Clin Transl Sci       Date:  2012-10-17       Impact factor: 4.689

4.  Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

Authors:  J A Heinsimer; A O Davies; R W Downs; M A Levine; A M Spiegel; M K Drezner; A De Lean; K A Wreggett; M G Caron; R J Lefkowitz
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Meera Sridharan; Shaquria Adderley; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

6.  Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.

Authors:  Randy S Sprague; Elizabeth A Bowles; Madelyn S Hanson; Eileen A DuFaux; Meera Sridharan; Shaquria Adderley; Mary L Ellsworth; Alan H Stephenson
Journal:  Microcirculation       Date:  2008-07       Impact factor: 2.628

7.  Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.

Authors:  Shaquria P Adderley; Eileen A Dufaux; Meera Sridharan; Elizabeth A Bowles; Madelyn S Hanson; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

8.  Erythrocyte G protein as a novel target for malarial chemotherapy.

Authors:  Sean C Murphy; Travis Harrison; Heidi E Hamm; Jon W Lomasney; Narla Mohandas; Kasturi Haldar
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

9.  Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate.

Authors:  Adrina Kalasho Kuzmiszyn; Anders Lund Selli; Natalia Smaglyukova; Timofei Kondratiev; Ole-Martin Fuskevåg; Roy Andre Lyså; Aina Westrheim Ravna; Torkjel Tveita; Georg Sager; Erik Sveberg Dietrichs
Journal:  Front Physiol       Date:  2022-07-13       Impact factor: 4.755

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.